Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-09-07
2008-12-02
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S249000, C544S250000, C544S252000
Reexamination Certificate
active
07459459
ABSTRACT:
Tri-heterocyclic compound of formula (I)wherein each of W, X and Y is carbon or nitrogen; each of U and Z is CR2, NR13, nitrogen, oxygen, sulfur etc.; A ring is carbocyclic ring, heterocyclic ring; R1is alkyl, alkenyl, alkynyl, NR4R5, OR6etc.; R3is carbocyclic ring, heterocyclic ring;and a pharmaceutically acceptable salt thereof, a process for the preparation thereof, a pharmaceutical comprising them as an active ingredient.A compound of formula (I) is useful, in order to possess corticotropin releasing factor receptor antagonistic activity, for the prevention and/or treatment of depression, anxiety, eating disorder, posttraumatic stress disorder, peptic ulcer, irritable bowl syndrome, Alzheimer's disease, drug addiction or alcohol dependence syndrome etc.
REFERENCES:
patent: 5420128 (1995-05-01), Kiyokawa et al.
patent: 5843951 (1998-12-01), Inoue et al.
patent: 7034153 (2006-04-01), Nakai et al.
patent: WO 92/06096 (1992-04-01), None
patent: WO 97/11946 (1997-04-01), None
patent: 99/64422 (1999-12-01), None
patent: 00/27846 (2000-05-01), None
patent: 00/27850 (2000-05-01), None
Sivakamasundari, et al., Pyrroloquinolines: Part IV—Synthesis of 1-Aryl-1H-pyrrolo[2,3-b]quinolines, Indian J. of Chem., vol. 26B, 744-47 (1987).
Tominaga, et al., Synthesis of Methylthiomaleimides for the Preparation of Pyridazines and Related Compounds, Journal of Heterocyclic Chemistry, 39(3), 571-591 (2002).
Leach, Colin A., et al., “Reversible Inhibitors of the Gastric (H+/K+) -ATPase, 2. 1-Arylpyrrolo [3,2-c] quinolines: Effect of the 4-Substituent”, J. Med. Chem., vol. 35, No. 10, 1992, pp. 1845 to 1852.
Sivakamasundari, S., et al/. “Pyrrologuinolines, Part IV, Synthesis of 1-aryl-1h-pyrrolo[2,3-b] quinolines” Indian J. Chem., Sect.B, vol. 26, No. 8, 1987, pp. 744 to 747.
Smith, Leon, et al., “Novel and highly efficient synthesis of the aza analogs of tacrine” Tetranedron Lett., vol. 40, No. 31, 1999, pp. 5643 to 5446.
Hirbert, Gerhard, et al., “(Aminoethinyl) metallierungen, 14, Cyclisierung von n1, n2-Diaryl-N1-Phenacyl-3-aminopropiolamidinen”, Liebigs Ann. Chem., (1985), (7) pp. 1389 t 1397.
Kagamiishi Yoshifumi
Nakai Hisao
Leeser Erich A
Ono Pharmaceutical Co. Ltd.
Sughrue & Mion, PLLC
Wilson James O.
LandOfFree
Tri-heterocyclic compounds and a pharmaceutical comprising... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tri-heterocyclic compounds and a pharmaceutical comprising..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tri-heterocyclic compounds and a pharmaceutical comprising... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4028751